Chambers Review
Provided by Chambers
Chambers Guide to the USA
Healthcare: Pharmaceutical/Medical Products Regulatory - District of Columbia
Individual Editorial
Philip Katz of Hogan Lovells US LLP is well noted for his expertise in an array of FDA matters. He has strength in issues relating to orphan drugs designation and regulatory exclusivity.